Genome editing in Parkinson's disease: Unlocking therapeutic avenues through CRISPR-Cas systems

Neurochemistry International 2026

View at publisher
Authors: Ravi Pratap Singh Singh, Prasenjit Maity, Charu Jaiswal
DOI: 10.1016/j.neuint.2026.106149
Cited by: 1
References: 155

Fields of Study & Subjects

CRISPR and Genetic Engineering Biotechnology and Related Fields Pluripotent Stem Cells Research

Publication details

Journal / source
Neurochemistry International
Publisher
Elsevier BV
Volume
196
Pages
106149–106149
Publication date
27 March 2026
Language
EN